SCYNEXIS, Inc. Interest Income, Other
SCYNEXIS, Inc. (SCYX) reported Interest Income, Other of $685.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-10
- SCYNEXIS, Inc. interest income, other for the quarter ending 2026-06-30 was $685.00K, a 34.31% increase year-over-year.
- SCYNEXIS, Inc. interest income, other for the quarter ending 2026-03-31 was $535.00K, a 31.06% decline year-over-year.
- SCYNEXIS, Inc. interest income, other for the quarter ending 2025-12-31 was $418.00K, a 51.90% decline year-over-year.
- SCYNEXIS, Inc. interest income, other for the quarter ending 2025-09-30 was $454.00K, a 55.49% decline year-over-year.
- SCYNEXIS, Inc. interest income, other for fiscal 2025 was $2.18M, a 49.27% decline from fiscal 2024.
- SCYNEXIS, Inc. interest income, other for fiscal 2024 was $4.29M, a 8.52% increase from fiscal 2023.
- SCYNEXIS, Inc. interest income, other for fiscal 2023 was $3.95M, a 179.43% increase from fiscal 2022.
- SCYNEXIS, Inc. interest income, other for fiscal 2022 was $1.42M, a 5795.83% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $685.00K 10-Q · filed 2026-08-10 | $1.17M 10-Q · filed 2026-08-10 | $1.64M derived: sum of 3 quarters · filed 2026-08-10 | $2.09M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $535.00K 10-Q · filed 2026-05-11 | $953.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.41M derived: sum of 3 quarters · filed 2026-05-11 | $1.92M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $872.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.38M derived: sum of 3 quarters · filed 2026-08-10 | $2.18M 10-K · filed 2026-03-04 |
| 2025-09-30 | $454.00K 10-Q · filed 2025-11-05 | $964.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.76M 10-Q · filed 2025-11-05 | $2.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $510.00K 10-Q · filed 2026-08-10 | $1.30M 10-Q · filed 2026-08-10 | $2.15M derived: sum of 3 quarters · filed 2026-08-10 | $3.17M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $776.00K 10-Q · filed 2026-05-11 | $1.65M derived: sum of 2 quarters · filed 2026-05-11 | $2.67M derived: sum of 3 quarters · filed 2026-05-11 | $3.79M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $869.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.89M derived: sum of 2 quarters · filed 2026-03-04 | $3.02M derived: sum of 3 quarters · filed 2026-03-04 | $4.29M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.02M 10-Q · filed 2025-11-05 | $2.15M derived: sum of 2 quarters · filed 2025-11-05 | $3.42M 10-Q · filed 2025-11-05 | $4.79M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.13M 10-Q · filed 2025-08-13 | $2.40M 10-Q · filed 2025-08-13 | $3.77M derived: sum of 3 quarters · filed 2025-08-13 | $5.04M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.28M 10-Q · filed 2025-05-15 | $2.64M derived: sum of 2 quarters · filed 2025-05-15 | $3.91M derived: sum of 3 quarters · filed 2025-05-15 | $4.64M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $2.63M derived: sum of 2 quarters · filed 2025-03-12 | $3.36M derived: sum of 3 quarters · filed 2025-03-12 | $3.95M 10-K · filed 2025-03-12 |
| 2023-09-30 | $1.26M 10-Q · filed 2024-11-06 | $2.00M derived: sum of 2 quarters · filed 2024-11-06 | $2.59M 10-Q · filed 2024-11-06 | $3.28M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $737.00K 10-Q · filed 2024-08-08 | $1.32M 10-Q · filed 2024-08-08 | $2.02M derived: sum of 3 quarters · filed 2024-08-08 | $2.55M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $587.00K 10-Q · filed 2024-05-08 | $1.28M derived: sum of 2 quarters · filed 2024-05-08 | $1.81M derived: sum of 3 quarters · filed 2024-05-08 | $1.99M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.22M derived: sum of 2 quarters · filed 2024-03-28 | $1.40M derived: sum of 3 quarters · filed 2024-03-28 | $1.42M 10-K · filed 2024-03-28 |
| 2022-09-30 | $531.00K 10-Q · filed 2023-11-13 | $712.00K derived: sum of 2 quarters · filed 2023-11-13 | $724.00K 10-Q · filed 2023-11-13 | $729.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $181.00K 10-Q · filed 2023-08-14 | $193.00K 10-Q · filed 2023-08-14 | $198.00K derived: sum of 3 quarters · filed 2023-08-14 | $206.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-10 | $17.00K derived: sum of 2 quarters · filed 2023-05-10 | $25.00K derived: sum of 3 quarters · filed 2023-05-10 | $31.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.00K derived: sum of 2 quarters · filed 2023-03-31 | $18.00K derived: sum of 3 quarters · filed 2023-03-31 | $24.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $8.00K 10-Q · filed 2022-11-09 | $14.00K derived: sum of 2 quarters · filed 2022-11-09 | $20.00K 10-Q · filed 2022-11-09 | $22.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-15 | $12.00K 10-Q · filed 2022-08-15 | $14.00K derived: sum of 3 quarters · filed 2022-08-15 | $19.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-12 | $8.00K derived: sum of 2 quarters · filed 2022-05-12 | $13.00K derived: sum of 3 quarters · filed 2022-05-12 | $49.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $6.00K derived: sum of 2 quarters · filed 2022-03-29 | $42.00K derived: sum of 3 quarters · filed 2022-03-29 | $189.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-10 | $41.00K derived: sum of 2 quarters · filed 2021-11-10 | $188.00K 10-Q · filed 2021-11-10 | $313.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $36.00K 10-Q · filed 2021-08-16 | $183.00K 10-Q · filed 2021-08-16 | $308.00K derived: sum of 3 quarters · filed 2021-08-16 | $478.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $147.00K 10-Q · filed 2021-05-17 | $272.00K derived: sum of 2 quarters · filed 2021-05-17 | $442.00K derived: sum of 3 quarters · filed 2021-05-17 | $675.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $295.00K derived: sum of 2 quarters · filed 2021-03-29 | $528.00K derived: sum of 3 quarters · filed 2021-03-29 | $805.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $170.00K 10-Q · filed 2020-11-06 | $403.00K derived: sum of 2 quarters · filed 2020-11-06 | $680.00K 10-Q · filed 2020-11-06 | $954.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $233.00K 10-Q · filed 2020-08-10 | $513.00K 10-Q · filed 2020-08-10 | $784.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.04M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $281.00K 10-Q · filed 2020-05-11 | $551.00K derived: sum of 2 quarters · filed 2020-05-11 | $811.00K derived: sum of 3 quarters · filed 2020-05-11 | $1.08M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $530.00K derived: sum of 2 quarters · filed 2020-03-11 | $801.00K derived: sum of 3 quarters · filed 2020-03-11 | $967.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $260.00K 10-Q · filed 2019-11-12 | $531.00K derived: sum of 2 quarters · filed 2019-11-12 | $697.00K 10-Q · filed 2019-11-12 | $823.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $271.00K 10-Q · filed 2019-08-07 | $437.00K 10-Q · filed 2019-08-07 | $563.00K derived: sum of 3 quarters · filed 2019-08-07 | $672.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $167.00K 10-Q · filed 2019-05-08 | $292.00K derived: sum of 2 quarters · filed 2019-05-08 | $401.00K derived: sum of 3 quarters · filed 2019-05-08 | $483.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $234.00K derived: sum of 2 quarters · filed 2019-03-14 | $316.00K derived: sum of 3 quarters · filed 2019-03-14 | $386.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $109.00K 10-Q · filed 2018-11-13 | $191.00K derived: sum of 2 quarters · filed 2018-11-13 | $261.00K 10-Q · filed 2018-11-13 | $330.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $82.00K 10-Q · filed 2018-08-09 | $150.00K 10-Q · filed 2018-08-09 | $221.00K derived: sum of 3 quarters · filed 2018-08-09 | $269.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $69.00K 10-Q · filed 2018-05-08 | $139.00K derived: sum of 2 quarters · filed 2018-05-08 | $187.00K derived: sum of 3 quarters · filed 2018-05-08 | $226.00K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $118.00K derived: sum of 2 quarters · filed 2018-03-13 | $157.00K derived: sum of 3 quarters · filed 2018-03-13 | $185.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $48.00K 10-Q · filed 2017-11-07 | $87.00K derived: sum of 2 quarters · filed 2017-11-07 | $115.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $39.00K 10-Q · filed 2017-08-08 | $67.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $28.00K 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |